Quantitative Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-7,284
Closed -$596K 484
2021
Q2
$596K Buy
7,284
+3,296
+83% +$274K 0.05% 269
2021
Q1
$379K Buy
+3,988
New +$377K 0.03% 379
2019
Q3
Sell
-28,681
Closed -$2.04M 697
2019
Q2
$2.04M Buy
+28,681
New +$2.11M 0.08% 285
2019
Q1
Sell
-25,969
Closed -$2.2M 757
2018
Q4
$2.2M Buy
+25,969
New +$2.77M 0.11% 175
2018
Q3
Sell
-12,503
Closed -$1.61M 769
2018
Q2
$1.61M Sell
12,503
-47,289
-79% -$5.28M 0.03% 405
2018
Q1
$6.16M Buy
59,792
+26,770
+81% +$2.65M 0.11% 235
2017
Q4
$2.82M Sell
33,022
-8,335
-20% -$722K 0.04% 433
2017
Q3
$3.51M Sell
41,357
-31,099
-43% -$2.46M 0.04% 404
2017
Q2
$5.49M Buy
+72,456
New +$5.07M 0.08% 310
2016
Q3
Sell
-30,136
Closed -$2.24M 776
2016
Q2
$2.24M Buy
30,136
+5,770
+24% +$428K 0.1% 266
2016
Q1
$1.63M Buy
24,366
+17,633
+262% +$1.07M 0.08% 302
2015
Q4
$455K Sell
6,733
-16,350
-71% -$1.01M 0.03% 514
2015
Q3
$1.23M Buy
+23,083
New +$1.4M 0.09% 263
2015
Q2
Sell
-9,618
Closed -$462K 595
2015
Q1
$462K Buy
+9,618
New +$369K 0.04% 370

Other funds holding LGND

Quantitative Investment Management's LGND Position: Q3 2021 in Review

Quantitative Investment Management sold out of Ligand Pharmaceuticals (LGND) in Q3 2021, closing a stake of 7,284 shares — an estimated $596K sold.

Quantitative Investment Management first reported a position in LGND in Q1 2015 and held it in 14 quarters. The position peaked at $6.16M in Q1 2018. 207 funds tracked by Wall St. Rank hold LGND as of Q3 2021.

  • Quantitative Investment Management reported no remaining Ligand Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Quantitative Investment Management sold 7,284 Ligand Pharmaceuticals shares in Q3 2021, an estimated $596K.
  • Quantitative Investment Management first reported a position in Ligand Pharmaceuticals in Q1 2015 and held it in 14 quarters.
  • Quantitative Investment Management's Ligand Pharmaceuticals position peaked at $6.16M in Q1 2018.
  • 207 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2021.

Based on Quantitative Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.